Skip to main content
Top
Published in: International Urology and Nephrology 4/2020

01-04-2020 | Nephrology - Original Paper

Normal white blood cell counts predict long-term mortality of hemodialysis patients

Authors: Efstathios Mitsopoulos, Aikaterini Lysitska, Stavros Zanos, Aikaterini Mplatsa, Maria-Eleni Alexandrou, Sofia Kevrekidou, Persia Stroppou, Ourania Zazopoulou, Theodora-Anastasia Kalliara, Anastasia Voudouri, Panagiotis Pateinakis, Eleni Manou, Parthena Kyriklidou, Dorothea Papadopoulou

Published in: International Urology and Nephrology | Issue 4/2020

Login to get access

Abstract

Purpose

It is unclear whether normal white blood cell (WBC) counts are predictive of subsequent mortality in hemodialysis patients.

Methods

All patients aged 17 years or more, who initiated hemodialysis at a tertiary Hospital from January 2000 to August 2017 with a dialysis vintage of greater than 90 days and normal median WBC count of their first dialysis year were included in the study. They were followed until they died, transferred to other dialysis facilities, switched to peritoneal dialysis, received a renal transplant or reached the end of the study (August 31, 2018). Cox regression was used to estimate hazard ratios for mortality of tertiles of WBC counts, adjusting for baseline demographic, clinical and laboratory variables.

Results

611 patients [median (interquartile range) age 65.2 (53.3–72.6) years, 62.4% male] were studied. During a median follow-up of 3.9 (1.6–7.2) years, 270 participants died. Patients in the mid- (6.25–7.73 × 103/μL, n = 203) and top-tertile (7.73–10.50 × 103/μL, n = 203) of normal WBC counts had significantly higher mortality than patients in the bottom-tertile (3.50–6.25 × 103/μL, n = 205). The adjusted hazard ratio for mortality relative to the bottom-tertile was 1.54, 95% confidence interval (CI) 1.05–2.25 and 2.20, 95% CI 1.46–3.32, for the mid- and top-tertiles, respectively.

Conclusions

In hemodialysis patients, higher WBC count within the normal range is associated with increased long-term mortality. This finding is described for the first time and provides further insight into the clinical significance of a “normal” WBC count result in dialysis patients.
Literature
2.
go back to reference Haapio M, Helve J, Grönhagen-Riska C, Finne P (2017) One- and 2-year mortality prediction for patients starting chronic dialysis. Kidney Int Rep 2(6):1176–1185CrossRef Haapio M, Helve J, Grönhagen-Riska C, Finne P (2017) One- and 2-year mortality prediction for patients starting chronic dialysis. Kidney Int Rep 2(6):1176–1185CrossRef
3.
go back to reference Doi T, Yamamoto S, Morinaga T, Sada KE, Kurita N, Onishi Y (2015) Risk score to predict 1-year mortality after hemodialysis initiation in patients with stage 5 chronic kidney disease under predialysis nephrology care. PLoS ONE 10(6):e0129180CrossRef Doi T, Yamamoto S, Morinaga T, Sada KE, Kurita N, Onishi Y (2015) Risk score to predict 1-year mortality after hemodialysis initiation in patients with stage 5 chronic kidney disease under predialysis nephrology care. PLoS ONE 10(6):e0129180CrossRef
4.
go back to reference Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS et al (2007) White blood cell count and mortality in the Baltimore longitudinal study of aging. J Am Coll Cardiol 49(18):1841–1850CrossRef Ruggiero C, Metter EJ, Cherubini A, Maggio M, Sen R, Najjar SS et al (2007) White blood cell count and mortality in the Baltimore longitudinal study of aging. J Am Coll Cardiol 49(18):1841–1850CrossRef
5.
go back to reference Nilsson G, Hedberg P, Ohrvik J (2014) White blood cell count in elderly is clinically useful in predicting long-term survival. J Aging Res 2014:475093CrossRef Nilsson G, Hedberg P, Ohrvik J (2014) White blood cell count in elderly is clinically useful in predicting long-term survival. J Aging Res 2014:475093CrossRef
6.
go back to reference Tamakoshi K, Toyoshima H, Yatsuya H, Matsushita K, Okamura T, Hayakawa T et al (2007) White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese. Circ J 71(4):479–485CrossRef Tamakoshi K, Toyoshima H, Yatsuya H, Matsushita K, Okamura T, Hayakawa T et al (2007) White blood cell count and risk of all-cause and cardiovascular mortality in nationwide sample of Japanese. Circ J 71(4):479–485CrossRef
7.
go back to reference Shankar A, Mitchell P, Rochtchina E, Wang JJ (2007) The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study. Atherosclerosis 192(1):177–183CrossRef Shankar A, Mitchell P, Rochtchina E, Wang JJ (2007) The association between circulating white blood cell count, triglyceride level and cardiovascular and all-cause mortality: Population-based cohort study. Atherosclerosis 192(1):177–183CrossRef
8.
go back to reference De Labry LO, Campion EW, Glynn RJ, Vokona PS (1990) White blood cell count as a predictor of mortality: results over 18 years from the normative aging study. J Clin Epidemiol 43(2):153–157CrossRef De Labry LO, Campion EW, Glynn RJ, Vokona PS (1990) White blood cell count as a predictor of mortality: results over 18 years from the normative aging study. J Clin Epidemiol 43(2):153–157CrossRef
9.
go back to reference Weijenberg MP, Feskens EJM, Kromhout D (1996) White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 16(4):499–503CrossRef Weijenberg MP, Feskens EJM, Kromhout D (1996) White blood cell count and the risk of coronary heart disease and all-cause mortality in elderly men. Arterioscler Thromb Vasc Biol 16(4):499–503CrossRef
10.
go back to reference Kabat GC, Kim MY, Manson JE, Lessin L, Lin J, Wassertheil-Smoler S, Rohan TE (2017) White blood cell count and total and cause-specific mortality in the women’s health initiative. Am J Epidemiol 186(1):63–72CrossRef Kabat GC, Kim MY, Manson JE, Lessin L, Lin J, Wassertheil-Smoler S, Rohan TE (2017) White blood cell count and total and cause-specific mortality in the women’s health initiative. Am J Epidemiol 186(1):63–72CrossRef
11.
go back to reference Shah AD, Thornley S, Chung SC, Denaxas S, Jackson R, Hemingway H (2017) White cell count in the normal range and short-term and long-term mortality: international comparisons of electronic health record cohorts in England and New Zealand. BMJ Open 7(2):e013100CrossRef Shah AD, Thornley S, Chung SC, Denaxas S, Jackson R, Hemingway H (2017) White cell count in the normal range and short-term and long-term mortality: international comparisons of electronic health record cohorts in England and New Zealand. BMJ Open 7(2):e013100CrossRef
12.
go back to reference Grimm RH, Neaton JD, Ludwig W (1985) Prognostic importance of the white blood cell count for coronary, cancer, and all cause mortality. JAMA 254(14):1932–1937CrossRef Grimm RH, Neaton JD, Ludwig W (1985) Prognostic importance of the white blood cell count for coronary, cancer, and all cause mortality. JAMA 254(14):1932–1937CrossRef
13.
go back to reference Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M et al (2005) Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women. Arch Intern Med 165(5):500–508CrossRef Margolis KL, Manson JE, Greenland P, Rodabough RJ, Bray PF, Safford M et al (2005) Leukocyte count as a predictor of cardiovascular events and mortality in postmenopausal women. Arch Intern Med 165(5):500–508CrossRef
14.
go back to reference Willems JM, Trompet S, Blauw GJ, Westendorp RG, de Craen AJ (2010) White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old. J Gerontol A Biol Sci Med Sci 65(7):764–768CrossRef Willems JM, Trompet S, Blauw GJ, Westendorp RG, de Craen AJ (2010) White blood cell count and C-reactive protein are independent predictors of mortality in the oldest old. J Gerontol A Biol Sci Med Sci 65(7):764–768CrossRef
15.
go back to reference Arain FA, Khaleghi M, Bailey KR, Lahr BD, Rooke TW, Kullo IJ (2009) White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. Am J Med 122(9):874.e1–7CrossRef Arain FA, Khaleghi M, Bailey KR, Lahr BD, Rooke TW, Kullo IJ (2009) White blood cell count predicts all-cause mortality in patients with suspected peripheral arterial disease. Am J Med 122(9):874.e1–7CrossRef
16.
go back to reference Cooper HA, Exner DV, Waclawiw MA, Domanski MJ (1999) White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 84(3):252–257CrossRef Cooper HA, Exner DV, Waclawiw MA, Domanski MJ (1999) White blood cell count and mortality in patients with ischemic and nonischemic left ventricular systolic dysfunction (an analysis of the Studies Of Left Ventricular Dysfunction [SOLVD]). Am J Cardiol 84(3):252–257CrossRef
17.
go back to reference Burr ML, Holliday RM, Fehily AM, Whitehead PJ (1992) Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 13(2):166–170CrossRef Burr ML, Holliday RM, Fehily AM, Whitehead PJ (1992) Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). Eur Heart J 13(2):166–170CrossRef
18.
go back to reference Venetz C, Labarere J, Jimenez D, Aujesky D (2013) White blood cell count and mortality in patients with acute pulmonary embolism. Am J Hematol 88(8):677–681CrossRef Venetz C, Labarere J, Jimenez D, Aujesky D (2013) White blood cell count and mortality in patients with acute pulmonary embolism. Am J Hematol 88(8):677–681CrossRef
19.
go back to reference Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O’Shea S, Owen WF et al (2003) White blood cells as a novel mortality predictor in hemodialysis patients. Nephrol Dial Transplant 18(6):1167–1173CrossRef Reddan DN, Klassen PS, Szczech LA, Coladonato JA, O’Shea S, Owen WF et al (2003) White blood cells as a novel mortality predictor in hemodialysis patients. Nephrol Dial Transplant 18(6):1167–1173CrossRef
20.
go back to reference Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ et al (2002) Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62(6):2238–2245CrossRef Pifer TB, McCullough KP, Port FK, Goodkin DA, Maroni BJ, Held PJ et al (2002) Mortality risk in hemodialysis patients and changes in nutritional indicators: DOPPS. Kidney Int 62(6):2238–2245CrossRef
21.
go back to reference Sun J, Axelsson J, Machowska A, Heimburger O, Barany P, Lindholm B et al (2016) Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol 11(7):1163–1172CrossRef Sun J, Axelsson J, Machowska A, Heimburger O, Barany P, Lindholm B et al (2016) Biomarkers of cardiovascular disease and mortality risk in patients with advanced CKD. Clin J Am Soc Nephrol 11(7):1163–1172CrossRef
22.
go back to reference Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C et al (2011) C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 6(10):2452–2461CrossRef Bazeley J, Bieber B, Li Y, Morgenstern H, de Sequera P, Combe C et al (2011) C-reactive protein and prediction of 1-year mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 6(10):2452–2461CrossRef
23.
go back to reference Hsu CW, Lin JL, Lin-Tan DT, Yen TH, Chen KH (2010) White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial 14(6):552–559CrossRef Hsu CW, Lin JL, Lin-Tan DT, Yen TH, Chen KH (2010) White blood cell count predicts all-cause, cardiovascular disease-cause and infection-cause one-year mortality of maintenance hemodialysis patients. Ther Apher Dial 14(6):552–559CrossRef
24.
go back to reference Asadollahi K, Beeching NJ, Gill GV (2010) Leukocytosis as a predictor for non-infective mortality and morbidity. QJM 103(5):285–292CrossRef Asadollahi K, Beeching NJ, Gill GV (2010) Leukocytosis as a predictor for non-infective mortality and morbidity. QJM 103(5):285–292CrossRef
25.
go back to reference Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928–935CrossRef Cook NR (2007) Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115(7):928–935CrossRef
26.
go back to reference Walker AE, Seibert SM, Donato AJ, Pierce GL, Seals DR (2010) Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension 55(2):363–369CrossRef Walker AE, Seibert SM, Donato AJ, Pierce GL, Seals DR (2010) Vascular endothelial function is related to white blood cell count and myeloperoxidase among healthy middle-aged and older adults. Hypertension 55(2):363–369CrossRef
27.
go back to reference Woodman RJ, Watts GF, Puddey IB, Burke V, Mori TA, Hodgson JM et al (2002) Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension. Atherosclerosis 163(1):175–181CrossRef Woodman RJ, Watts GF, Puddey IB, Burke V, Mori TA, Hodgson JM et al (2002) Leukocyte count and vascular function in Type 2 diabetic subjects with treated hypertension. Atherosclerosis 163(1):175–181CrossRef
28.
29.
go back to reference Sinisalo J, Paronen J, Mattila KJ, Syrjala M, Alfthan G, Palosuo T et al (2000) Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 149(2):403–411CrossRef Sinisalo J, Paronen J, Mattila KJ, Syrjala M, Alfthan G, Palosuo T et al (2000) Relation of inflammation to vascular function in patients with coronary heart disease. Atherosclerosis 149(2):403–411CrossRef
30.
go back to reference Shankar A, Klein BEK, Klein R (2004) Relationship between white blood cell count and incident hypertension. Am J Hypertens 17(3):233–239CrossRef Shankar A, Klein BEK, Klein R (2004) Relationship between white blood cell count and incident hypertension. Am J Hypertens 17(3):233–239CrossRef
31.
go back to reference Quellet G, Malhotra R, Penne EL, Usvya L, Levin NW, Kotanko P (2016) Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients. Clin Nephrol 85(4):191–198 Quellet G, Malhotra R, Penne EL, Usvya L, Levin NW, Kotanko P (2016) Neutrophil-lymphocyte ratio as a novel predictor of survival in chronic hemodialysis patients. Clin Nephrol 85(4):191–198
32.
go back to reference Sato H, Takeuchi Y, Matsuda K, Kagaya S, Saito A, Fukami H et al (2017) Pre-dialysis neutrophil-lymphocyte ratio, a novel and strong short-term predictor of all-cause mortality in patients with diabetic nephropathy: results from a single-center study. Ther Apher Dial 21(4):370–377CrossRef Sato H, Takeuchi Y, Matsuda K, Kagaya S, Saito A, Fukami H et al (2017) Pre-dialysis neutrophil-lymphocyte ratio, a novel and strong short-term predictor of all-cause mortality in patients with diabetic nephropathy: results from a single-center study. Ther Apher Dial 21(4):370–377CrossRef
Metadata
Title
Normal white blood cell counts predict long-term mortality of hemodialysis patients
Authors
Efstathios Mitsopoulos
Aikaterini Lysitska
Stavros Zanos
Aikaterini Mplatsa
Maria-Eleni Alexandrou
Sofia Kevrekidou
Persia Stroppou
Ourania Zazopoulou
Theodora-Anastasia Kalliara
Anastasia Voudouri
Panagiotis Pateinakis
Eleni Manou
Parthena Kyriklidou
Dorothea Papadopoulou
Publication date
01-04-2020
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 4/2020
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-020-02431-z

Other articles of this Issue 4/2020

International Urology and Nephrology 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.